Cancer Chronic Pain Predicted by Emotional and Cognitive Status
CanoPEe
1 other identifier
observational
89
1 country
1
Brief Summary
The aim of this study is to investigate the predictive dimension of cognitive-emotional status of cancer patients on the chronic pain development 6 months after different cancer treatment protocol (surgery, chemotherapy, radiotherapy, hormone therapy, targeted therapy ...).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2016
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2016
CompletedFirst Submitted
Initial submission to the registry
April 13, 2016
CompletedFirst Posted
Study publicly available on registry
May 19, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 15, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
November 12, 2018
CompletedApril 2, 2020
May 1, 2016
2.6 years
April 13, 2016
March 31, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Measure of average pain intensity by a numerical rating scale
Measure of average pain intensity by a numerical rating scale assessed 7 days before the 6 months visit after inclusion of patients.
7 days before the visit
Secondary Outcomes (19)
Pain assessment by numerical rating scale and DN4
at baseline
Pain assessment by numerical rating scale and DN4
at 6 months
Pain assessment by numerical rating scale and DN4
at 12 months
Pain assessment by numerical rating scale and DN4
at 24 months
Pain assessment by numerical rating scale and DN4
2 days after each cancer treatment protocol
- +14 more secondary outcomes
Study Arms (1)
cancer patients
Interventions
Eligibility Criteria
cancer patients
You may qualify if:
- Age ≥ 18 years
- Cancer patient with one or more programmed cancer treatment protocols (chemotherapy, surgery, hormone therapy, radiation therapy, targeted therapy, ...)
- Acceptance to sign the non-opposition form
You may not qualify if:
- History of cancer and cancer treatment protocols (chemotherapy, surgery, hormone therapy, radiation therapy, targeted therapy, ...)
- History and/or presence of primary brain tumors (glioblastoma, meningioma, neurofibroma ...)
- History of neurological disorders (Parkinson's disease, Alzheimer's disease, dementia, epilepsy, moderate to severe head injury, ...)
- History of psychiatric disorders (schizophrenia, bipolar disorder, ...)
- Medical and surgical history incompatible with the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Clermont-Ferrand
Clermont-Ferrand, 63003, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gisèle PICKERING
University Hospital, Clermont-Ferrand
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 13, 2016
First Posted
May 19, 2016
Study Start
March 1, 2016
Primary Completion
October 15, 2018
Study Completion
November 12, 2018
Last Updated
April 2, 2020
Record last verified: 2016-05